Canaccord Genuity Group Inc. (TSX:CF)
| Market Cap | 1.22B +48.7% |
| Revenue (ttm) | 1.95B +22.7% |
| Net Income | -216.70M |
| EPS | -2.20 |
| Shares Out | 100.44M |
| PE Ratio | n/a |
| Forward PE | 9.82 |
| Dividend | 0.34 (2.80%) |
| Ex-Dividend Date | Feb 27, 2026 |
| Volume | 115,502 |
| Average Volume | 95,324 |
| Open | 12.29 |
| Previous Close | 12.25 |
| Day's Range | 12.00 - 12.29 |
| 52-Week Range | 8.70 - 13.82 |
| Beta | 1.72 |
| RSI | 49.00 |
| Earnings Date | Jun 5, 2026 |
About Canaccord Genuity Group
Canaccord Genuity Group Inc., a full-service financial services company, provides investment products, and investment banking and brokerage services to institutional, corporate, and private clients. It operates in two segments, Canaccord Genuity Capital Markets and Canaccord Genuity Wealth Management. The Canaccord Genuity Capital Markets segment offers investment banking, advisory, research, merger and acquisition, sales, and trading services. The Canaccord Genuity Wealth Management segment provides wealth management solutions, and brokerage a... [Read more]
Financial Performance
In fiscal year 2025, Canaccord Genuity Group's revenue was 1.64 billion, an increase of 18.10% compared to the previous year's 1.39 billion. Losses were -28.91 million, 17.6% more than in 2024.
Financial StatementsNews
QuantumCore to Present at Canaccord Genuity Virtual Quantum Symposium
Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - QuantumCore Ltd. (CSE: QNCR) ("QuantumCore" or the "Company"), a developer of advanced quantum infrastructure technologies, today announced its parti...
BLUENERGIES ANNOUNCES FINANCIAL ADVISORY AGREEMENTS WITH HAYWOOD SECURITIES INC. AND CANACCORD GENUITY CORP.
TSXV: BLU | OTCQX: BLUGF VANCOUVER, BC, April 16, 2026 /PRNewswire/ - BluEnergies Ltd. (TSXV: BLU) ("BLU" or the "Company") announces it has entered into new strategic advisory services agreements (th...
Canaccord Genuity announces $80M settlement with U.S. agencies
Canaccord Genuity (CCORF) announced that its U.S. broker-dealer subsidiary has entered into final settlement agreements with the Securities and Exchange Commission, the Financial Industry Regulatory A...
Canaccord Genuity price target raised to C$16 from C$14 at TD Securities
TD Securities analyst Graham Ryding raised the firm’s price target on Canaccord Genuity (CCORF) to C$16 from C$14 and keeps a Buy rating on the shares.
CANACCORD GENUITY GROUP INC. BOLSTERS ITS CAPITAL MARKETS ADVISORY CAPABILITY WITH ACQUISITION OF LEADING ADVISOR TO THE RENEWABLE ENERGY SECTOR
TORONTO, Jan. 14, 2026 /PRNewswire/ - Canaccord Genuity Group Inc. (TSX: CF) (the "Company" or "Canaccord Genuity") is pleased to announce that through its U.S. capital markets business it has acquire...
Canaccord Genuity price target raised to C$14 from C$12 at TD Securities
TD Securities analyst Graham Ryding raised the firm’s price target on Canaccord Genuity (CCORF) to C$14 from C$12 and keeps a Buy rating on the shares.
EBR Systems to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world's only left ventricular wireless cardiac pacing device for heart failure, today announced that management will be particip...
Octave Bioscience to Participate in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a leading precision care company that is delivering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseas...
Canaccord confirms strategic review of British wealth unit, says no deal assured
Canaccord Genuity said on Friday it is evaluating options for its British wealth management business and had met with potential counterparties.
Exclusive: Canaccord Genuity in early talks over possible sale of British wealth arm, sources say
Canadian financial services group Canaccord Genuity has been sounding out potential bidders, including CVC and Advent, for its British wealth arm, two people with knowledge of the matter told Reuters.
TD Securities upgrades Canaccord Genuity on constructive wealth business view
As previously reported, TD Securities analyst Graham Ryding upgraded Canaccord Genuity (CCORF) to Buy from Hold with a price target of C$12, up from C$10, citing a more constructive view…
Canaccord Genuity upgraded to Buy from Hold at TD Securities
TD Securities analyst Graham Ryding upgraded Canaccord Genuity (CCORF) to Buy from Hold with a price target of C$12, up from C$10.
TMX Group CFO David Arnold to Present at the Canaccord Genuity 45th Annual Growth Conference
Toronto, Ontario--(Newsfile Corp. - July 29, 2025) - TMX Group CFO David Arnold will present at the Canaccord Genuity 45th Annual Growth Conference on Wednesday, August 13, 2025 from 1:00 p.m. to 1:25...
CMG to Participate in the Canaccord Genuity 45th Annual Growth Conference
CALGARY, Alberta, July 29, 2025 (GLOBE NEWSWIRE) -- Computer Modelling Group Ltd. (“CMG” or the “Company”) (TSX: CMG) is pleased to announce that it will participate in the upcoming Canaccord Genuity ...
Tesla's stock driven by robotaxi excitement, says Canaccord Genuity's George Gianarikas
Canaccord Genuity's George Gianarikas and CNBC's Phil LeBeau discuss Tesla's latest deliveries data, the robotaxi story and much more.
Canaccord Genuity upgraded to Buy from Market Perform at Cormark
Cormark upgraded Canaccord Genuity (CCORF) to Buy from Market Perform with a C$11.25 price target
Spine BioPharma, Inc. to Present at the Canaccord Genuity 2025 Musculoskeletal Conference
NEW YORK--(BUSINESS WIRE)--Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc Disease (DDD), today announced that Chief Executive ...
IDEX Metals Engages Canaccord Genuity and Red Cloud to Lead Subscription Receipt Financing
Not for distribution to U.S. news wire services or for dissemination in the United States
Canaccord Genuity downgraded to Hold at TD Securities on elevated expenses
As previously reported, TD Securities downgraded Canaccord Genuity (CCORF) to Hold from Buy with a price target of C$10, down from C$12, after quarterly results were below the firm’s forecast…
Canaccord Genuity downgraded to Hold from Buy at TD Securities
TD Securities downgraded Canaccord Genuity (CCORF) to Hold from Buy with a price target of C$10, down from C$12.
We're at the beginning of an 'energy supercycle,' says Canaccord Genuity's George Gianarikas
George Gianarikas, Canaccord Genuity senior analyst, joins CNBC's 'The Exchange' to discuss why he's anticipating major moves in energy stocks.
TSX / Canaccord Genuity International Oil & Gas Investor Day Opens the Market
Toronto, Ontario--(Newsfile Corp. - December 11, 2024) - Representatives from Canaccord Genuity Group Inc. (TSX: CF) (Canaccord Genuity), joined Berk Sumen, Managing Director, Company Services, Toront...
Canaccord Genuity price target raised to C$13 from C$11 at Raymond James
Raymond James raised the firm’s price target on Canaccord Genuity (CCORF) to C$13 from C$11 and keeps a Strong Buy rating on the shares.
Revolo Announces Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference
GAITHERSBURG, Md. and CAMBRIDGE, United Kingdom, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics Limited (“Revolo”) today announced that President and Chief Executive Officer, Woody Bryan, Ph...
Converge Technology Solutions Announces Participation in the Canaccord Genuity 44th Annual Growth Conference
TORONTO and GATINEAU, QC, Aug. 6, 2024 /PRNewswire/ - Converge Technology Solutions Corp. ("Converge" or the "Company") (TSX: CTS) is pleased to announce its participation in the Canaccord Genuity 44t...